14 Results for "

galectin-9

" in MedChemExpress (MCE) Product Catalog:
Products (14)

14 Results for "galectin-9" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-P70535
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: galectin-9; Gal-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72637
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: galectin-9; Lgals9; Gal-9
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P990242
Anti-Mouse Galectin-9 Antibody (RG9-1) is an anti-mouse Galectin-9 IgG2b monoclonal antibody. Anti-Mouse Galectin-9 Antibody (RG9-1) promotes inflammatory response by enhancing the secretion of IFN-γ, TNF-α, and IL-6. Anti-Mouse Galectin-9 Antibody (RG9-1) can increase CD8 T cell and Treg frequency. Anti-Mouse Galectin-9 Antibody (RG9-1) reduces graft survival time by increasing CD4 + and CD8 + T cell infiltration. Anti-Mouse Galectin-9 Antibody (RG9-1) can be used for researches on inflammation conditions, cancer and xenotransplantation such as ischemia-reperfusion, colon cancer, breast cancer and leukemia .
loading...
    loading...
Cat. No.: HY-159884
CAS No.: 328540-44-9
Target:  

Tim3 TNF Receptor IFNAR

Research Areas:  

Cancer

MG-T-19 is a potent small-molecule inhibitor targeting human TIM-3. MG-T-19 blocks the interactions between TIM-3 and its ligands such as phosphatidylserine, CEACAM1 and Galectin-9. MG-T-19 promotes the secretion of TNF-α and IFN-γ by peripheral blood mononuclear cells, and significantly enhances their ability to inhibit cancer cell proliferation. MG-T-19 can be used in studies related to acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-P990004

Target:  

Tim3

Research Areas:  

Inflammation/Immunology Cancer

Anti-Mouse TIM-3 Antibody (B8.2C12) is an anti-mouse TIM-3 IgG1 monoclonal antibody. Anti-Mouse TIM-3 Antibody (B8.2C12) can block the binding of Tim-3 with Phosphatidylserine (PtdSer) and CEACAM1 without interfering with the binding to Galectin-9. Anti-Mouse TIM-3 Antibody (B8.2C12) can inhibit tumor growth and activate tumor infiltrating CD8 + T cells. Anti-Mouse TIM-3 Antibody (B8.2C12) can be used for studying cancer such as breast cancer and colon cancer and constructing experimental autoimmune encephalomyelitis (EAE) models .
loading...
    loading...
Cat. No.: HY-P991198

Target:  

Tim3

Research Areas:  

Cancer

M6903 is a humanized monoclonal IgG2 antibody targeting T cell immunoglobulin and mucin domain-3 (TIM-3) (KD for human TIM-3 is 2.3 nM). M6903 binds to TIM-3, blocking the binding of TIM-3 to phosphatidylserine (PtdSer), carcinoembryonic antigen cell adhesion-related molecule 1 (CEACAM1), and galectin 9 (Gal-9), thus relieving TIM-3-mediated T cell inhibition and exerting the activities of activating antigen-specific T cells and enhancing anti-tumor immunity. M6903 is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-P81382
Synonyms: galectin 9; HUAT; LGALS9A

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P81382A
Synonyms: galectin 9; HUAT; LGALS9A

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P85876

Host:  

Mouse

Application:  

WB, ICC/IF, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P705214
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: galectin-9; Gal-9; Ecalectin; Tumor Antigen HOM-HD-21; LGALS9
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P70696
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: galectin-9; Gal-9; Ecalectin; Tumor antigen HOM-HD-21; LGALS9; Gal-9delta5
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P700082AF
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: G-CSF; CSF-3; MGI-1G; Pluripoietin; Molgramostin; Sargramostim
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS16866
Research Areas:  

Others

Lgals9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Lgals9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P992366

Target:  

Galectin Tim3

Research Areas:  

Cancer

HFB200901 is a galectin LGALS9 inhibitor and immunostimulant that can be used in studies related to pancreatic adenocarcinoma, pancreatic intraepithelial neoplasia, KRAS G12C-mutant colon cancer, and prostate cancer. HFB200901 disrupts the LGALS9/TIM-3 axis, while blocking the internalization and vacuolization of recombinant LGALS9. HFB200901 reduces the proportion of regulatory T cells (Treg) and enhances dendritic cell activation, thereby inducing polyfunctional and memory CD8 + T cell responses. HFB200901 inhibits the progression of pancreatic neoplastic lesions and effectively improves the efficacy of PSMA-based vaccination .
loading...
    loading...
  • 1